Zepbound KwikPen 8.33 mg/mL
tirzepatide · INJECTION, SOLUTION · Eli Lilly and Company
No Recall History
Plain English
Zepbound KwikPen is a injection, solution containing tirzepatide at 8.33 mg/mL, taken subcutaneous. Manufactured by Eli Lilly and Company.
Key Facts
- Brand Name
- Zepbound KwikPen
- Generic Name
- tirzepatide
- NDC Code (Product)
0002-3555- Manufacturer
- Eli Lilly and Company
- Strength
- 8.33 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- NDA217806
- Drug Class
- Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]; GLP-1 Receptor Agonist [EPC]
- Marketing Start
- 01/20/2026
Recall History
No Recall HistoryFrequently Asked Questions
What is Zepbound KwikPen used for?
Zepbound KwikPen contains tirzepatide. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is Zepbound KwikPen a controlled substance?
Zepbound KwikPen is not classified as a controlled substance by the DEA.
What is the generic name for Zepbound KwikPen?
The generic name for Zepbound KwikPen is tirzepatide. There are 11 other brand versions of tirzepatide.
What is the NDC code for Zepbound KwikPen 8.33 mg/mL?
The NDC (National Drug Code) for Zepbound KwikPen 8.33 mg/mL is 0002-3555, listed by Eli Lilly and Company.